James L. Wilder

415 total citations
6 papers, 312 citations indexed

About

James L. Wilder is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, James L. Wilder has authored 6 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Obstetrics and Gynecology, 4 papers in Reproductive Medicine and 2 papers in Pathology and Forensic Medicine. Recurrent topics in James L. Wilder's work include Endometrial and Cervical Cancer Treatments (4 papers), Uterine Myomas and Treatments (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). James L. Wilder is often cited by papers focused on Endometrial and Cervical Cancer Treatments (4 papers), Uterine Myomas and Treatments (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). James L. Wilder collaborates with scholars based in United States. James L. Wilder's co-authors include Marcus E. Randall, Frederick R. Ueland, Milton Raben, Kathryn M. Greven, Richard J. Kryscio, Paul D. DePriest, Edward J. Pavlik, Albert J. Peters, Shahin Shajahan and John R. van Nagell and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics and Gynecologic Oncology.

In The Last Decade

James L. Wilder

6 papers receiving 307 citations

Peers

James L. Wilder

OG

RM

SURGE

PRM

ONCOL

David L. Marchetti United States

Masashi Nishiya Japan

Bastiaan G. Wortman Netherlands

Piotr Sobiczewski Poland

J. van Nagell United States

Kelly Underhill United States

Susan K. Gibbons United States

Jinghe Lang China

Danielle C. Costigan United States

Anjali R. Jotwani United States

David L. Marchetti United States

James L. Wilder

138 ×0.6

OG

171 ×0.8

RM

68 ×1.3

SURGE

54 ×1.0

PRM

75 ×2.0

ONCOL

Citations per year, relative to James L. Wilder James L. Wilder (= 1×) peers David L. Marchetti

Countries citing papers authored by James L. Wilder

Since Specialization

Citations

This map shows the geographic impact of James L. Wilder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L. Wilder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L. Wilder more than expected).

Fields of papers citing papers by James L. Wilder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James L. Wilder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L. Wilder. The network helps show where James L. Wilder may publish in the future.

Co-authorship network of co-authors of James L. Wilder

This figure shows the co-authorship network connecting the top 25 collaborators of James L. Wilder. A scholar is included among the top collaborators of James L. Wilder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James L. Wilder. James L. Wilder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Modesitt, Susan C., Paul D. DePriest, Frederick R. Ueland, et al.. (2005). The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC). Gynecologic Oncology. 99(3). 557–563. 53 indexed citations

2.

Shajahan, Shahin, Chendil Damodaran, James L. Wilder, et al.. (2003). Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT. Gynecologic Oncology. 91(1). 9–14. 64 indexed citations

3.

Wilder, James L., Shahin Shajahan, Nada H. Khattar, et al.. (2003). Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-α, estrogen-β and progesterone; a case controlled study. Gynecologic Oncology. 92(2). 553–558. 25 indexed citations

4.

Wilder, James L., Edward J. Pavlik, J. Michael Straughn, et al.. (2003). Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation☆. Gynecologic Oncology. 89(2). 233–235. 57 indexed citations

5.

Randall, Marcus E., James L. Wilder, Kathryn M. Greven, & Milton Raben. (1990). Role of intracavitary cuff boost after adjuvant external irradiation in early endometrial carcinoma. International Journal of Radiation Oncology*Biology*Physics. 19(1). 49–54. 58 indexed citations

6.

Curran, Walter J., Richard Whittington, James Fanning, et al.. (1989). Analysis of failure patterns in stage III endometrial carcinoma and therapeutic implications. International Journal of Radiation Oncology*Biology*Physics. 17(1). 35–39. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact